Krista Todoric, MD
Allergy & Immunology · Mechanicsburg, PANPI 1093973091
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by ARS Pharmaceuticals Operations, Inc. at 40.8% of the total. 2025 is the largest year on record at $22,871, more than ten times the $872 reported in 2020.
Across 836 payments — averaging $51.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ARS Pharmaceuticals Operations, Inc.$18K
- Optinose US, Inc.$10K
- AstraZeneca$4K
- Regeneron Healthcare Solutions, Inc.$2K
- GSK$2K
- Sanofi$1K
- plus $6K from 29 others
What the payments were for
- Consulting fees$3,0007%
- Speaking & faculty fees$20,66148%
- Travel & lodging$2,4366%
- Food & beverage$16,27538%
- Education$5841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 13 | $17,531 |
| Optinose US, Inc. | 26 | $9,581 |
| AstraZeneca | 205 | $4,207 |
| Regeneron Healthcare Solutions, Inc. | 98 | $2,105 |
| GSK | 148 | $1,985 |
| Sanofi | 61 | $1,329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 39 | $1,007 |
| Pfizer | 51 | $815 |
| Amgen(2 entities) | 32 | $691 |
| Grifols USA, LLC | 21 | $431 |
| Novartis | 19 | $399 |
| CSL Behring | 15 | $393 |
| Genentech USA, Inc. | 13 | $337 |
| Biocryst US Sales Co., LLC | 14 | $306 |
| AbbVie | 11 | $258 |
| LEO Pharma Inc. | 9 | $181 |
| Sanofi-aventis U.S. LLC | 2 | $178 |
| Kaleo, Inc. | 8 | $175 |
| Covis Pharma GmbH | 7 | $169 |
| Teva Pharmaceuticals USA, Inc. | 7 | $132 |
| Lilly USA, LLC | 5 | $99 |
| Blueprint Medicines Corporation | 3 | $93 |
| Pharming Healthcare, Inc. | 5 | $89 |
| Boehringer Ingelheim | 5 | $83 |
| Aimmune Therapeutics, Inc. | 4 | $80 |
| Mylan Specialty L.p. | 2 | $58 |
| Incyte Corporation | 2 | $41 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Eyevance Pharmaceuticals LLC | 2 | $31 |
| Bio Products Laboratory USA, Inc. | 2 | $30 |
| Organon | 1 | $25 |
| X4 Pharmaceuticals, Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Biocryst Pharmaceuticals, Inc. | 1 | $21 |
| Greer Laboratories, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,956 in reported general payments places this provider in the 85th percentile of 175 allergy & immunology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 17 | $380,621 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 91 | $93,952 |
| FasenraBenralizumab | 13 | $73,277 |
| Dupixent PenDupilumab | 15 | $59,709 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 76 | $58,293 |
| Spiriva RespimatTiotropium Bromide | 62 | $43,560 |
| XhanceFluticasone Propionate | 35 | $38,162 |
| XolairOmalizumab | 15 | $36,255 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $15,202 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $8,722 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 40 | $7,531 |
| Mometasone Furoate | 55 | $5,785 |
| OdactraMite,d.Farinae-D.Pteronyssinus | 13 | $4,435 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $4,321 |
| Azelastine Hcl | 109 | $3,244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Cuvitru | $1,007 | $380,62117 claims |
| AstraZenecaFasenra, Breztri Aerosphere | $4,207 | $131,57089 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,985 | $111,931129 claims |
| Boehringer IngelheimSpiriva Respimat | $83 | $43,56062 claims |
| Optinose US, Inc.Xhance | $9,581 | $38,16235 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 175 allergy & immunology providers in Pennsylvania.
Other allergy & immunology in Mechanicsburg
- Donald HarperMechanicsburg$142K
- Jack ArmstrongMechanicsburg$85K
- Drew WeissmanPhiladelphia$12.8M
- Eric SchenkelBethlehem$845K
- Sergei BelenkyPittsburgh$775K
- Timothy CraigHershey$564K
- Sandra GawchikUpland$390K
- Anthony RooklinGlen Mills$319K
- Corinna BowserNarberth$229K
- Shailen ShahCollegeville$183K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.